{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/otitis-media-acute/prescribing-information/amoxicillin/","result":{"pageContext":{"chapter":{"id":"15d20ee0-531c-5230-9e41-6194bfbe3614","slug":"amoxicillin","fullItemName":"Amoxicillin","depth":2,"htmlHeader":"<!-- begin field d7fb79b8-a11a-4d2b-befa-a74c00d0d61a --><h2>Amoxicillin</h2><!-- end field d7fb79b8-a11a-4d2b-befa-a74c00d0d61a -->","summary":"","htmlStringContent":"<!-- begin item 2ae2346d-c264-46eb-b4ac-a74c00d0d5aa --><!-- end item 2ae2346d-c264-46eb-b4ac-a74c00d0d5aa -->","topic":{"id":"0671aacb-4e00-5bb2-8b54-aa0da27fb4ab","topicId":"009f13e7-d649-401b-8b63-061c029e67f2","topicName":"Otitis media - acute","slug":"otitis-media-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"793c7288-db92-5c67-8ef6-0ea9a20f6b09","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0cbb536b-178c-5bea-a1c6-22c584a7e1b6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"944570b9-0a8f-5b67-8ee8-556c3fd8a613","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"aedad1bf-9c58-57d9-9c3d-d1fa6e40ee13","slug":"changes","fullItemName":"Changes"},{"id":"7bc4152c-a9f8-5afe-bb63-2a48a86ebf0d","slug":"update","fullItemName":"Update"}]},{"id":"cd84410b-569d-58a4-8fe8-c2eaed2ead26","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7875d022-7cbf-5961-a19e-d5987af92edc","slug":"goals","fullItemName":"Goals"},{"id":"8db5ac64-8db5-5daa-aa3c-d46caaf0abf3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3517d1cc-7aae-5036-81f5-ac0b590e84fd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4ca0ace8-77fc-5319-95e0-e983fa092ed9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f87cf2b3-b0ea-5485-b424-9518a3f586a2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e285c16b-d4ba-56b6-a3fd-3c27fc822357","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"749e39ba-56ce-5129-8e10-fef140b586c2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9df3117d-949e-56bb-ac40-0393fb87071a","slug":"definition","fullItemName":"Definition"},{"id":"cb42b641-fdc3-5bd6-a13a-ca2c1edd9c21","slug":"causes","fullItemName":"Causes"},{"id":"2682b3f3-3099-54c9-9c02-867b7f3350e0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a7d4a184-6baa-5ae6-baef-11eba15038e6","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fc412f0f-261f-5fae-a125-cfeefdd5e8b3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"18e296ab-cfe3-58be-bf23-aaf4a6c6f49e","slug":"complications","fullItemName":"Complications"}]},{"id":"a0da1ac3-73ef-561b-9301-a1ccdf5fd8a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9e9b0e14-9f7d-5c5a-83a1-c4bfd193ba3d","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"7e76e099-c70a-5f57-b670-c0ad43913066","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"0dac3638-3899-5899-bd0e-647894c3f003","fullItemName":"Management","slug":"management","subChapters":[{"id":"35db78a7-148c-5b20-8fd7-54ea5aaba599","slug":"acute-otitis-media-initial-presentation","fullItemName":"Scenario: Acute otitis media - initial presentation"},{"id":"4d27de1d-1fe0-5438-98c0-f85415825ca5","slug":"persistent-acute-otitis-media-treatment-failure","fullItemName":"Scenario: Persistent acute otitis media - treatment failure"},{"id":"7d848f0c-bb0a-5ea7-90f2-dd99a1cbc49e","slug":"recurrent-acute-otitis-media","fullItemName":"Scenario: Recurrent acute otitis media"}]},{"id":"c8285b67-3320-54ae-8537-4c0626e3632e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f512abb6-f15e-5fef-9f9d-23e008c401ff","slug":"analgesia","fullItemName":"Analgesia"},{"id":"15d20ee0-531c-5230-9e41-6194bfbe3614","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"859385d7-8fde-5b5e-8357-c34d3500eeb7","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"bb1b0220-4609-5ab7-8102-e31414c36dab","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"0f55a4d8-b11d-53a6-a26e-b2a9e98e8dd8","slug":"erythromycin","fullItemName":"Erythromycin"}]},{"id":"f43bc1b4-a67e-5bab-b27c-d141e7483b01","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"51596c5b-15a7-547d-bdcf-f7a467961cd7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f91fb8f9-4942-5683-8b3d-d8edd775f700","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c2fdf612-fff8-581e-bf78-7c9efcf08ddf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2bb0e3c7-8948-5401-97a7-741ffa1d4477","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"570abb9c-faad-515e-86bb-0b947414dcb9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5e5c540f-ce64-5768-9c46-dfde85f5364a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7f9af8df-6314-54fa-a769-b5bd0bd121ab","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c8285b67-3320-54ae-8537-4c0626e3632e","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"9bbcba58-d3cb-54d7-9997-7b77e29752d6","slug":"dosing-regime","fullItemName":"Dosing regime","depth":3,"htmlHeader":"<!-- begin field e87d574f-53a0-41d9-86d1-a74c00d0ff96 --><h3>Dosing regime</h3><!-- end field e87d574f-53a0-41d9-86d1-a74c00d0ff96 -->","summary":"","htmlStringContent":"<!-- begin item 462f44ba-cc7f-4d8f-88a5-a74c00d0fe76 --><!-- begin field 3ff4fdfb-3406-4a9d-af12-a74c00d0ff96 --><ul><li><strong>The treatment duration for acute otitis media is 5–7 days.</strong></li><li><strong>In children,</strong> prescribe: <ul><li>Child 1 –11 months: 125 mg three times a day.</li><li>Child 1–4 years: 250 mg three times a day.</li><li>Child 5–17 years: 500 mg three times a day.</li></ul></li><li><strong>The dose should be reduced in children (weighing 40 kg or less) with renal impairment:</strong><ul><li>If the glomerular filtration rate (GFR) is 10–30 mL/minute, prescribe 15 mg/kg twice daily (maximum 500 mg twice daily).</li><li>If the GFR is less than 10 mL/minute, prescribe 15 mg/kg but only once daily (maximum 500 mg).</li></ul></li><li><strong>In adults,</strong> prescribe 500 mg three times a day.</li><li><strong>The dose should be reduced in adults (and children weighing more than 40 kg) with renal impairment</strong>. If the GFR is less than 30 mL/minute an increase in the dosage interval and a reduction in the total daily dose is recommended: <ul><li>If GFR is 10–30 mL/minute, prescribe a maximum 500 mg twice a day.</li><li>If GFR is less than 10 mL/minute, prescribe a maximum 500 mg once a day.     </li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">NICE, 2018a</a>]</p><!-- end field 3ff4fdfb-3406-4a9d-af12-a74c00d0ff96 --><!-- end item 462f44ba-cc7f-4d8f-88a5-a74c00d0fe76 -->","subChapters":[]},{"id":"be5bbf43-25af-529e-b331-56acc084a67c","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 66a65637-e573-4275-afc8-a74c00d110f6 --><h3>Contraindications and cautions</h3><!-- end field 66a65637-e573-4275-afc8-a74c00d110f6 -->","summary":"","htmlStringContent":"<!-- begin item b3bd0f71-7937-49ca-b8a7-a74c00d11059 --><!-- begin field 9d4c2934-dfdc-43db-b18b-a74c00d110f6 --><ul><li><strong>Do not prescribe amoxicillin to people with </strong><ul><li>A <em>true</em> penicillin hypersensitivity. Allergic reactions to penicillins occur in 1–10% of exposed individuals. Anaphylactic reactions occur in fewer than 0.05% of treated patients.<ul><li>Gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do <em>not</em> constitute an allergy to penicillin.</li></ul></li><li>Hypersensitivity to cephalosporins.</li></ul></li><li><strong>Prescribe amoxicillin with caution in people with:</strong><ul><li>Renal impairment — it may be necessary to reduce the dose of amoxicillin. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/otitis-media-acute/prescribing-information/amoxicillin/#dosing-regime\">Dosing regime</a> for more information.</li><li>Glandular fever (infective mononucleosis) — these people are especially susceptible to amoxicillin-induced skin rashes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>]</p><!-- end field 9d4c2934-dfdc-43db-b18b-a74c00d110f6 --><!-- end item b3bd0f71-7937-49ca-b8a7-a74c00d11059 -->","subChapters":[]},{"id":"e8e5f83d-8fee-51b7-b4c1-490b26762c0f","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 3d2cc678-59a7-451e-b58c-a74c00d11f6a --><h3>Adverse effects</h3><!-- end field 3d2cc678-59a7-451e-b58c-a74c00d11f6a -->","summary":"","htmlStringContent":"<!-- begin item ac8bbed7-fd22-4775-a081-a74c00d11e4f --><!-- begin field 71796d9d-4cda-48cf-8cdf-a74c00d11f6a --><ul><li><strong>The most common adverse effects of penicillins include</strong> diarrhoea, nausea, and skin rash.<ul><li>Severe diarrhoea during or after treatment with antibiotics may be a sign of pseudomembranous colitis (PMC). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li><li>In addition to rash, other skin symptoms include urticaria and pruritus. Very rarely, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis and acute generalised exanthematous pustulosis have been reported.</li></ul></li><li><strong>Anaphylaxis (immediate or delayed)</strong> is a serious but rare adverse effect of amoxicillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li><li>Other very rare adverse effects include:<ul><li>Hepatitis, cholestatic jaundice.</li><li>Hyperkinesia, dizziness, convulsions.</li><li>Interstitial nephritis.</li><li>Leucopenia, thrombocytopenia, haemolytic anaemia.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>]</p><ul></ul><!-- end field 71796d9d-4cda-48cf-8cdf-a74c00d11f6a --><!-- end item ac8bbed7-fd22-4775-a081-a74c00d11e4f -->","subChapters":[]},{"id":"faf55d90-3998-5da9-8795-8d2227f99032","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 0cfb9543-8333-44e2-93ba-a74c00d12fdf --><h3>Drug interactions</h3><!-- end field 0cfb9543-8333-44e2-93ba-a74c00d12fdf -->","summary":"","htmlStringContent":"<!-- begin item e818512d-82a9-4e56-bb31-a74c00d12f14 --><!-- begin field 5391ce5f-0a4d-4bdb-8220-a74c00d12fdf --><ul><li><strong>Allopurinol</strong> — be aware that concomitant use of allopurinol and amoxicillin may increase the incidence of skin rashes. Concomitant use need not be avoided for this reason.</li><li><strong>Anticoagulants (for example warfarin)</strong> — monitor the prothrombin time or international normalized ratio (INR) more closely with the addition or withdrawal of a penicillin. Adjustment of the anticoagulant dose may be necessary.<ul><li>Prolongation of INR has been reported in people taking penicillins and warfarin concurrently.</li></ul></li><li><strong>Methotrexate</strong> — monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected.<ul><li>Penicillins may reduce the excretion of methotrexate, potentially increasing toxicity. The interaction is not usually serious and risk factors are unknown (even people on low doses of methotrexate have been affected).</li></ul></li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are <em>not</em> required during or after courses of penicillins.<ul><li>However, advise women on the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the section on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li><li><strong>Probenecid</strong> — may cause increased and prolonged blood levels of amoxicillin. Manufacturer recommends avoiding concurrent use.</li><li><strong>Tetracyclines</strong> — the bactericidal effects of amoxicillin may be affected by concurrent tetracycline use.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">Preston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">FSRH, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>]</p><!-- end field 5391ce5f-0a4d-4bdb-8220-a74c00d12fdf --><!-- end item e818512d-82a9-4e56-bb31-a74c00d12f14 -->","subChapters":[]},{"id":"d846c353-84f3-5daa-9419-1a09ed13d0b3","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field a2e95db0-a8b2-4a24-9f94-a74c00d14204 --><h3>Pregnancy and breastfeeding</h3><!-- end field a2e95db0-a8b2-4a24-9f94-a74c00d14204 -->","summary":"","htmlStringContent":"<!-- begin item c8b81418-48ec-4f48-8bb0-a74c00d14174 --><!-- begin field 203c81b9-ce9d-42bf-b32a-a74c00d14204 --><h4>Pregnancy</h4><ul><li>Amoxicillin is not known to be harmful in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>]. <ul><li>Penicillins are the antibiotics of choice in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">Schaefer, 2015</a>]. The UK Teratology Information Service (UKTIS) states that the most of a large amount of data shows no increased risk of congenital malformation, spontaneous abortion, intrauterine death, low birth weight, preterm delivery, or neonatal complications when penicillins are taken at therapeutic doses during pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">UKTIS, 2017</a>].  </li></ul></li></ul><h4>Breastfeeding</h4><ul><li>Trace amounts of amoxicillin are found in breastmilk, but it is appropriate to use in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">BNF 75, 2018</a>].  <ul><li>Penicillins (and cephalosporins) are the antibiotics of choice in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">Schaefer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-media-acute/references/\">Kearney, 2016</a>]. <strong> </strong></li></ul></li></ul><!-- end field 203c81b9-ce9d-42bf-b32a-a74c00d14204 --><!-- end item c8b81418-48ec-4f48-8bb0-a74c00d14174 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}